Clinical trial · Observational
Concordance of the Biology of Primary Breast Carcinoma and the Biology of Recurrence .
Concordance of the Biology of Primary Breast Carcinoma and the Biology of Recurrence , Retrospective Study.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
the study will discuss the concordance of the biology of primary breast carcinoma and the biology of recurrence. The study will be conducted at Department of Clinical Oncology, Sohag University Hospital and Sohag Cancer center, Sohag, Egypt. including Patients diagnosed and treated between 2015 and 2025 and Data will be collected from medical records, pathology reports, and radiology reports.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Carcinoma | Breast Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Rate of receptor discordance between primary and recurrent breast cancer.
- timeFrame
- 2015-2025
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age more than18 years old at time of diagnosis of breast cancer. * Patients who had recurrent breast cancer following adjuvant treatment. * Biopsy was taken from the site of recurrence and biology was done. Exclusion Criteria: * Patients with distant metastasis at time of presentation. * Patients diagnosed with double malignancy. * Patients with incomplete data records. * Recurrent breast cancer and biopsy difficult to be taken .
References
Publications (0)
Data not yet available